Remove Clinical Trials Remove Oil Remove Research and Development Remove Treatment
article thumbnail

CBD Oil’s Wide Availablity Challenges Medical Research

Puff Puff Post

A multitude of stores sell CBD (cannabidiol) oil now that hemp is legal. State regulations on CBD oil vary from US state to US state. Generally, states and regulators dissuade retailers from selling non-approved substances as medications, but a variety of people use CBD oil for a various medicinal purposes.

CBD 52
article thumbnail

CBD Oil’s Wide Availablity Challenges Medical Research

Puff Puff Post

A multitude of stores sell CBD (cannabidiol) oil now that hemp is legal. State regulations on CBD oil vary from US state to US state. Generally, states and regulators dissuade retailers from selling non-approved substances as medications, but a variety of people use CBD oil for a various medicinal purposes.

CBD 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Effectiveness Of CBD: Is It A Safe Treatment For Seizures And Epilepsy?

Cannabis Law Report

Several companies are facilitating the development of this product. More research is still needed to explore this uncharted territory. CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. However, deeper research is needed to better understand its roles. Flashing lights.

article thumbnail

CBD Science Update

Project CBD

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218
article thumbnail

Veterans and Medical Cannabis: A Comprehensive Guide

MMJ Recs

In this instance, medical cannabis offers a promising alternative or complementary treatment option. There are multiple US states with an established state-approved medical marijuana program as well as states permitting the use of cannabinol (CBD) oil – a non-psychoactive component of cannabis – for medical purposes exclusively.

article thumbnail

Prohibition Publish 2nd Ed Of The Pharmaceutical Cannabis Report

Cannabis Law Report

The use of cannabinoids in the treatment of medical conditions offers major opportunities and challenges to anyone operating in the space. Prohibition Partners has identified at least 30 late-stage clinical trials using cannabinoid therapeutics, any of which will probably have a large impact on the medicinal cannabis space.

article thumbnail

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

Cannabis Law Report

OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has completed the acquisition of leading oncology research and development company Sapphire Biotech, Inc. (“Sapphire”). Valencia has stewarded Sapphire in the development of its unique patent-pending pipeline. CEO Dr. Stuart Titus.